ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 136 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,473,707 | +173.4% | 283,417 | +214.9% | 0.00% | +100.0% |
Q1 2024 | $2,733,330 | -76.7% | 90,001 | -78.4% | 0.00% | -66.7% |
Q4 2023 | $11,720,806 | +478.1% | 417,259 | +458.6% | 0.00% | +200.0% |
Q3 2023 | $2,027,303 | -48.5% | 74,698 | -41.7% | 0.00% | 0.0% |
Q2 2023 | $3,938,931 | +192.8% | 128,137 | +243.2% | 0.00% | 0.0% |
Q1 2023 | $1,345,108 | +22.4% | 37,333 | +34.2% | 0.00% | 0.0% |
Q4 2022 | $1,099,288 | +46.8% | 27,816 | +49.1% | 0.00% | – |
Q3 2022 | $749,000 | +208.2% | 18,650 | +222.1% | 0.00% | – |
Q2 2022 | $243,000 | -97.5% | 5,790 | -97.7% | 0.00% | -100.0% |
Q1 2022 | $9,703,000 | -47.8% | 249,072 | -46.6% | 0.00% | -40.0% |
Q4 2021 | $18,580,000 | -10.3% | 466,259 | -18.7% | 0.01% | -37.5% |
Q3 2021 | $20,725,000 | +150.3% | 573,465 | +183.9% | 0.01% | +166.7% |
Q2 2021 | $8,280,000 | -63.7% | 202,007 | -61.4% | 0.00% | -72.7% |
Q1 2021 | $22,816,000 | +210.8% | 523,037 | +256.6% | 0.01% | +175.0% |
Q4 2020 | $7,342,000 | +1201.8% | 146,691 | +994.7% | 0.00% | – |
Q3 2020 | $564,000 | -72.6% | 13,400 | -68.4% | 0.00% | -100.0% |
Q2 2020 | $2,060,000 | – | 42,425 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
Brown University | 381,759 | $19,107,000 | 13.82% |
Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |